Cargando…

PSA bouncing after brachytherapy HDR and external beam radiation therapy: a study of 121 patients with minimum 5-years follow-up

PURPOSE: To determine the clinical and dosimetric factors that predict prostate-specific antygen (PSA) bouncing following brachytherapy HDR and three-dimensional conformal radiation therapy (3D-CRT) for prostate cancer patients. MATERIAL AND METHODS: The evaluated population consisted of 121 prostat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Makarewicz, Roman, Lebioda, Andrzej, Terlikiewicz, Joanna, Biedka, Marta, Wiśniewski, Tomasz
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Termedia Publishing House 2009
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5075994/ https://www.ncbi.nlm.nih.gov/pubmed/27795718

Ejemplares similares

Interstitial brachytherapy for penile cancer: the experience of Oncology Centre in Bydgoszcz
por: Makarewicz, Roman, et al.
Publicado: (2011)

Time to PSA rise differentiates the PSA bounce after HDR and LDR brachytherapy of prostate cancer
por: Burchardt, Wojciech, et al.
Publicado: (2018)

Oxidative Stress Markers in Prostate Cancer Patients after HDR Brachytherapy Combined with External Beam Radiation
por: Woźniak, Alina, et al.
Publicado: (2012)

Tumour and immune cell dynamics explain the PSA bounce after prostate cancer brachytherapy
por: Yamamoto, Yoichiro, et al.
Publicado: (2016)

3D-image-guided HDR-brachytherapy versus 2D HDR - brachytherapy after external beam radiotherapy for early T-stage nasopharyngeal carcinoma
por: Ren, YuFeng, et al.
Publicado: (2014)

Predictors of distant metastasis after combined HDR brachytherapy and external beam radiation for prostate cancer
por: Kamrava, Mitchell, et al.
Publicado: (2013)

HDR brachytherapy (HDR–BT) combined with stent placement in palliative treatment of esophageal cancer
por: Kanikowski, Marek, et al.
Publicado: (2009)

Permanent (125)I-seed prostate brachytherapy: early prostate specific antigen value as a predictor of PSA bounce occurrence
por: Mazeron, Renaud, et al.
Publicado: (2012)

Prostate brachytherapy: HDR or seed implant
por: Das, K. R.
Publicado: (2006)

Vital role of volume and number of needles in HDR brachytherapy (HDR-BT) of prostate cancer
por: Chicheł, Adam, et al.
Publicado: (2009)

The use of nomograms in LDR-HDR prostate brachytherapy
por: Pujades, Ma Carmen, et al.
Publicado: (2011)

Dose correction in lung for HDR breast brachytherapy
por: Slessinger, Eric, et al.
Publicado: (2012)

Individualized Dose-Escalation of HDR Prostate Brachytherapy Implant to Decrease Required External Beam Radiation Dose: A Retrospective Feasibility Study
por: Dahn, Hannah M., et al.
Publicado: (2019)

Characteristics of PSA Bounce after Radiotherapy for Prostate Cancer: A Meta-Analysis
por: Darwis, Narisa Dewi Maulany, et al.
Publicado: (2020)

Minimal percentage of dose received by 90% of the urethra (%UD90) is the most significant predictor of PSA bounce in patients who underwent low-dose-rate brachytherapy (LDR-brachytherapy) for prostate cancer
por: Tanaka, Nobumichi, et al.
Publicado: (2012)

External Validation of a Predictive Model of Urethral Strictures for Prostate Patients Treated With HDR Brachytherapy Boost
por: Panettieri, Vanessa, et al.
Publicado: (2020)

HDR Brachytherapy in the Management of High-Risk Prostate Cancer
por: Masson, Susan, et al.
Publicado: (2012)

Dosimetric comparison of surface mould HDR brachytherapy with VMAT
por: Boman, Eeva L., et al.
Publicado: (2018)

Prostate Specific Antigen (PSA) as Predicting Marker for Clinical Outcome and Evaluation of Early Toxicity Rate after High-Dose Rate Brachytherapy (HDR-BT) in Combination with Additional External Beam Radiation Therapy (EBRT) for High Risk Prostate Cancer
por: Ecke, Thorsten H., et al.
Publicado: (2016)

The analysis of the long-term outcomes in elderly women treated for locally advanced cervical cancer
por: Koper, Krzysztof, et al.
Publicado: (2018)

Interstitial HDR brachytherapy (HDR-BT) in early stage mobile tongue cancers in young patients – Gliwice experience
por: Kellas-Ślęczka, Sylwia, et al.
Publicado: (2010)

Comparison of (60)Co and (192)Ir sources in HDR brachytherapy
por: Strohmaier, Stefan, et al.
Publicado: (2011)

Ir-192 Calibration in Air with Farmer Chamber for HDR Brachytherapy
por: Chang, Liyun, et al.
Publicado: (2016)

HDR Brachytherapy Dose Distribution is Influenced by the Metal Material of the Applicator
por: Wu, Chin-Hui, et al.
Publicado: (2015)

Corrigendum to “HDR Brachytherapy in the Management of High-Risk Prostate Cancer”
por: Masson, Susan, et al.
Publicado: (2016)

Comparison of two planning systems for HDR brachytherapy gynecological application
por: Elhanafy, Osman A., et al.
Publicado: (2001)

High Dose Rate (HDR) Brachytherapy for Mycosis Fungoides of the Wrist
por: Shukla, Gaurav, et al.
Publicado: (2015)

MR-guided HDR prostate brachytherapy with teleoperated steerable needles
por: de Vries, M., et al.
Publicado: (2023)

Penile cancer brachytherapy HDR mould technique used at the Holycross Cancer Center
por: Matys, Robert, et al.
Publicado: (2011)

Evaluation of Brain Edema Formation Defined By MRI After LINAC-based Stereotactic Radiosurgery
por: Harat, Maciej, et al.
Publicado: (2017)

Basal Cell Carcinoma Treated with High Dose Rate (HDR) Brachytherapy—Early Evaluation of Clinical and Dermoscopic Patterns during Irradiation
por: Krzysztofiak, Tomasz, et al.
Publicado: (2021)

Dosimetry evaluation of SAVI-based HDR brachytherapy for partial breast irradiation
por: Manoharan, Sivasubramanian R., et al.
Publicado: (2010)

Optimizing parametrial aperture design utilizing HDR brachytherapy isodose distribution
por: Chapman, Katherine L., et al.
Publicado: (2013)

Custom-designed mouthpiece for HDR brachytherapy of embryonal rhabdomyosarcoma of the soft palate
por: Ekwelundu, Emmanuel, et al.
Publicado: (2014)

HDR endobronchial brachytherapy in palliative and combined radical treatment of lung cancer
por: Fijuth, Jacek
Publicado: (2010)

Is there any place for LDR brachytherapy for head and neck carcinomas in HDR era?
por: Fijuth, Jacek
Publicado: (2009)

HDR brachytherapy as a solution in recurrences of locally advanced prostate cancer
por: Łyczek, Jarosław, et al.
Publicado: (2009)

VMAT for the treatment of gynecologic malignancies for patients unable to receive HDR brachytherapy
por: Merrow, Caitlin, et al.
Publicado: (2014)

Development, implementation, and associated challenges of a new HDR brachytherapy program
por: Scanderbeg, Daniel J., et al.
Publicado: (2020)

Simple phantom fabrication for MRI‐based HDR brachytherapy applicator commissioning
por: Fagerstrom, Jessica M., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_sc1jic4nk6htr0omtebqier4qa